198 related articles for article (PubMed ID: 15333967)
1. Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia.
Hatzitolios A; Savopoulos C; Lazaraki G; Sidiropoulos I; Haritanti P; Lefkopoulos A; Karagiannopoulou G; Tzioufa V; Dimitrios K
Indian J Gastroenterol; 2004; 23(4):131-4. PubMed ID: 15333967
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hyperlipidemia in nonalcoholic fatty liver disease: fat for thought.
Adams LA; Lindor KD
Indian J Gastroenterol; 2004; 23(4):127-8. PubMed ID: 15333965
[No Abstract] [Full Text] [Related]
3. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia.
Zhu FS; Liu S; Chen XM; Huang ZG; Zhang DW
World J Gastroenterol; 2008 Nov; 14(41):6395-400. PubMed ID: 19009658
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial.
Foster T; Budoff MJ; Saab S; Ahmadi N; Gordon C; Guerci AD
Am J Gastroenterol; 2011 Jan; 106(1):71-7. PubMed ID: 20842109
[TBL] [Abstract][Full Text] [Related]
5. Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study.
Athyros VG; Mikhailidis DP; Didangelos TP; Giouleme OI; Liberopoulos EN; Karagiannis A; Kakafika AI; Tziomalos K; Burroughs AK; Elisaf MS
Curr Med Res Opin; 2006 May; 22(5):873-83. PubMed ID: 16709309
[TBL] [Abstract][Full Text] [Related]
6. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease.
Zelber-Sagi S; Kessler A; Brazowsky E; Webb M; Lurie Y; Santo M; Leshno M; Blendis L; Halpern Z; Oren R
Clin Gastroenterol Hepatol; 2006 May; 4(5):639-44. PubMed ID: 16630771
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of short-term safety and efficacy of HMG-CoA reductase inhibitors in hypercholesterolemic patients with elevated serum alanine transaminase concentrations: PITCH study (PITavastatin versus atorvastatin to evaluate the effect on patients with hypercholesterolemia and mild to moderate hepatic damage).
Han KH; Rha SW; Kang HJ; Bae JW; Choi BJ; Choi SY; Gwon HC; Bae JH; Hong BK; Choi DH; Han KR
J Clin Lipidol; 2012; 6(4):340-51. PubMed ID: 22836071
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients.
Gómez-Domínguez E; Gisbert JP; Moreno-Monteagudo JA; García-Buey L; Moreno-Otero R
Aliment Pharmacol Ther; 2006 Jun; 23(11):1643-7. PubMed ID: 16696815
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of Orlistat in the treatment of severe hypertriglyceridemia.
Wierzbicki AS; Reynolds TM; Crook MA
Am J Cardiol; 2002 Jan; 89(2):229-31. PubMed ID: 11792350
[No Abstract] [Full Text] [Related]
10. A role for atorvastatin and insulin combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia.
Matafome P; Nunes E; Louro T; Amaral C; Crisóstomo J; Rodrigues L; Moedas AR; Monteiro P; Cipriano A; Seiça R
Naunyn Schmiedebergs Arch Pharmacol; 2009 Mar; 379(3):241-51. PubMed ID: 18936912
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins.
Sposito AC; Santos RD; Amâncio RF; Ramires JA; Chapman MJ; Maranhão RC
Atherosclerosis; 2003 Feb; 166(2):311-21. PubMed ID: 12535744
[TBL] [Abstract][Full Text] [Related]
12. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.
Kiyici M; Gulten M; Gurel S; Nak SG; Dolar E; Savci G; Adim SB; Yerci O; Memik F
Can J Gastroenterol; 2003 Dec; 17(12):713-8. PubMed ID: 14679419
[TBL] [Abstract][Full Text] [Related]
14. [The use of atorvastatin in patients with rheumatoid arthritis with hyperlipidemia].
Nikitina NM; Rebrov AP
Kardiologiia; 2009; 49(9):21-6. PubMed ID: 19772499
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of ezetimibe added to atorvastatin versus up titration of atorvastatin to 40 mg in Patients > or = 65 years of age (from the ZETia in the ELDerly [ZETELD] study).
Zieve F; Wenger NK; Ben-Yehuda O; Constance C; Bird S; Lee R; Hanson ME; Jones-Burton C; Tershakovec AM
Am J Cardiol; 2010 Mar; 105(5):656-63. PubMed ID: 20185012
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy and safety of atorvastatin initiated at different starting doses in patients with dyslipidemia.
Jones PH; McKenney JM; Karalis DG; Downey J
Am Heart J; 2005 Jan; 149(1):e1. PubMed ID: 15660024
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a low dose of pitavastatin compared with atorvastatin in primary hyperlipidemia: results of a 12-week, open label study.
Yoshitomi Y; Ishii T; Kaneki M; Tsujibayashi T; Sakurai S; Nagakura C; Miyauchi A
J Atheroscler Thromb; 2006 Apr; 13(2):108-13. PubMed ID: 16733299
[TBL] [Abstract][Full Text] [Related]
18. Effect of atorvastatin and diet on non-alcoholic fatty liver disease activity score in hyperlipidemic chickens.
Martín-Castillo A; Castells MT; Adánez G; Polo MT; Pérez BG; Ayala I
Biomed Pharmacother; 2010 Apr; 64(4):275-81. PubMed ID: 19932590
[TBL] [Abstract][Full Text] [Related]
19. Effect of atorvastatin, vitamin E and C on nonalcoholic fatty liver disease: is the combination required?
Arendt BM; Allard JP
Am J Gastroenterol; 2011 Jan; 106(1):78-80. PubMed ID: 21212755
[TBL] [Abstract][Full Text] [Related]
20. Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).
Bays HE; Dujovne CA; McGovern ME; White TE; Kashyap ML; Hutcheson AG; Crouse JR;
Am J Cardiol; 2003 Mar; 91(6):667-72. PubMed ID: 12633795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
